OncoSec Medical Inc (ONCS):医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7916)
◆英語タイトル:OncoSec Medical Inc (ONCS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7916
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:48
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. OncoSec is conducting pipeline programs for various indications which include metastatic melanoma, triple negative breast cancer and solid tumors. It is also identifying and developing novel immune-targeting agents for use with the ImmunoPulse platform. The company conducts pre-clinical and clinical studies targeting various cancers in collaboration with various academic medical centers and companies. OncoSec is headquartered in San Diego, California, the US.

OncoSec Medical Inc (ONCS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OncoSec Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OncoSec Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
OncoSec Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
OncoSec Medical Inc, Medical Equipment, Deal Details 11
Partnerships 11
OncoSec Medical Enters into Agreement with Jounce Therapeutics 11
OncoSec Medical Enters into Agreement with Inhibrx 12
OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 13
Equity Offering 14
OncoSec Medical Raises USD8 Million in First Tranche of Private Placement of Shares 14
OncoSec Medical Raises USD23 Million in Public Offering of Shares 15
OncoSec Medical Plans to Raise up to USD16 Million in Public Offering of Shares 16
OncoSec Medical to Raise USD9.3 Million in Private Placement of Shares upon Exercise of Warrants 17
OncoSec Medical Raises USD7 Million in Private Placement of Shares 18
Oncosec Medical Raises USD5 Million in Private Placement of Shares upon Exercise of Warrants 20
OncoSec Medical Plans to Raise up to USD8.4 Million in Public Offering of Shares 21
OncoSec Medical Raises USD10 Million in Registered Direct Offering 22
OncoSec Medical Raises USD13.6 Million in Private Placement of Shares 23
OncoSec Medical Raises USD16 Million in Private Placement of Shares and Warrants 24
OncoSec Medical Completes Private Placement Of Shares For US$12 Million 25
OncoSec Medical Completes Private Placement Of Common Stock For US$7 Million 26
OncoSec Medical Completes Public Offering Of Units For US$8 Million 27
OncoSec Medical Inc – Key Competitors 29
OncoSec Medical Inc – Key Employees 30
OncoSec Medical Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Financial Announcements 32
Jun 01, 2017: OncoSec Announces Third Quarter and YTD Results for Fiscal Year 2017 32
Mar 16, 2017: OncoSec Announces Second Quarter and YTD Results for Fiscal Year 2017 34
Corporate Communications 35
Jul 30, 2018: OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory 35
Jul 16, 2018: OncoSec names Sara M. Bonstein as chief financial officer and chief operating officer 36
Jan 16, 2018: OncoSec Appoints Veteran Biopharma Executive Gregory T. Mayes To Board Of Directors 37
Dec 05, 2017: OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to CSO 38
Nov 07, 2017: OncoSec Appoints Daniel J. O’Connor as Chief Executive Officer to Lead Next Stage of Growth as a Fully Integrated Late Stage Development and Commercial Company 39
Sep 07, 2017: OncoSec Appoints Industry Leader Daniel J. O’Connor to its Board of Directors 40
Sep 05, 2017: OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of Directors 41
Legal and Regulatory 42
Jun 25, 2018: OncoSec added to the Russell Microcap Index 42
Product News 43
Nov 28, 2017: OncoSec Expands Intellectual Property Estate, Announces Issuance of Patents for ImmunoPulse® Platform 43
May 02, 2017: OncoSec to Present at Biomarkers & Immuno-Oncology World Congress 2017 44
Other Significant Developments 45
Jun 28, 2018: OncoSec provides outlook for second half of 2018 45
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
OncoSec Medical Inc, Medical Equipment, Key Facts, 2017 2
OncoSec Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OncoSec Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OncoSec Medical Inc, Deals By Market, 2012 to YTD 2018 9
OncoSec Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
OncoSec Medical Enters into Agreement with Jounce Therapeutics 11
OncoSec Medical Enters into Agreement with Inhibrx 12
OncoSec Medical Enters into Research Agreement with University of California and PerkinElmer 13
OncoSec Medical Raises USD8 Million in First Tranche of Private Placement of Shares 14
OncoSec Medical Raises USD23 Million in Public Offering of Shares 15
OncoSec Medical Plans to Raise up to USD16 Million in Public Offering of Shares 16
OncoSec Medical to Raise USD9.3 Million in Private Placement of Shares upon Exercise of Warrants 17
OncoSec Medical Raises USD7 Million in Private Placement of Shares 18
Oncosec Medical Raises USD5 Million in Private Placement of Shares upon Exercise of Warrants 20
OncoSec Medical Plans to Raise up to USD8.4 Million in Public Offering of Shares 21
OncoSec Medical Raises USD10 Million in Registered Direct Offering 22
OncoSec Medical Raises USD13.6 Million in Private Placement of Shares 23
OncoSec Medical Raises USD16 Million in Private Placement of Shares and Warrants 24
OncoSec Medical Completes Private Placement Of Shares For US$12 Million 25
OncoSec Medical Completes Private Placement Of Common Stock For US$7 Million 26
OncoSec Medical Completes Public Offering Of Units For US$8 Million 27
OncoSec Medical Inc, Key Competitors 29
OncoSec Medical Inc, Key Employees 30
OncoSec Medical Inc, Other Locations 31

List of Figures
OncoSec Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
OncoSec Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
OncoSec Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OncoSec Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
OncoSec Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OncoSec Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ OncoSec Medical Inc (ONCS):医療機器:M&Aディール及び事業提携情報(OncoSec Medical Inc (ONCS) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆